RETRACTED: p53 gene (Gendicine) and embolisation overcame recurrent hepatocellular carcinoma (Retracted Article)

被引:15
作者
Guan, YS [1 ]
Liu, Y [1 ]
Zhou, XP [1 ]
Li, X [1 ]
He, Q [1 ]
Sun, L [1 ]
机构
[1] Sichuan Univ, W China Hosp, Dept Radiol, Chengdu 610041, Sichuan Provinc, Peoples R China
关键词
D O I
10.1136/gut.2005.069237
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Transcatheter arterial chemoembolisation (TACE) has become the standard treatment for unresectable hepatocellular carcinoma (HCC). However, this method is often unsuccessful. The p53 gene, which is present as a mutant form in many human tumours, is known to have broad spectrum antitumour effects when expressed normally. In this study, we report a 23 year old patient with recurrent HCC who was treated with the p53 gene (Gendicine) combining TACE, which resulted in a good clinical prognosis.
引用
收藏
页码:1318 / 1319
页数:2
相关论文
共 13 条
[1]
Fan J, 1998, WORLD J GASTROENTERO, V4, P33
[2]
FRIEDMANN T, 1992, CANCER, V70, P1810, DOI 10.1002/1097-0142(19920915)70:4+<1810::AID-CNCR2820701624>3.0.CO
[3]
2-3
[4]
Multidetector CT in evaluating blood supply of hepatocellular carcinoma after transcatheter arterial chemoembolization [J].
Guan, Yong-Song ;
Zheng, Xiao-Hua ;
Zhou, Xiang-Ping ;
Huang, Juan ;
Sun, Long ;
Chen, Xian ;
Li, Xiao ;
He, Qing .
WORLD JOURNAL OF GASTROENTEROLOGY, 2004, 10 (14) :2127-2129
[5]
Hsia CC, 2000, ONCOL REP, V7, P353
[6]
Progress in cancer gene therapy [J].
Kouraklis, G .
ACTA ONCOLOGICA, 1999, 38 (06) :675-683
[7]
Segmental transcatheter arterial embolization for primary hepatocellular carcinoma [J].
Li, L ;
Wu, PH ;
Li, JQ ;
Zhang, WZ ;
Lin, HG ;
Zhang, YQ .
WORLD JOURNAL OF GASTROENTEROLOGY, 1998, 4 (06) :511-512
[8]
LIN DY, 1997, J GASTROEN HEPATOL, V12, P319
[9]
Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival [J].
Llovet, JM ;
Bruix, J .
HEPATOLOGY, 2003, 37 (02) :429-442
[10]
Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma:: a randomised controlled trial [J].
Llovet, JM ;
Real, MI ;
Montaña, X ;
Planas, R ;
Coll, S ;
Aponte, J ;
Ayuso, C ;
Sala, M ;
Muchart, J ;
Solà, R ;
Rodés, J ;
Bruix, J .
LANCET, 2002, 359 (9319) :1734-1739